Back to Agenda
SESSION 3 : New Era for Product Information in Digital Health and Pharmacovigilance
Session Chair(s)
Shun Jin, MBA
Head – BD & RA, PharmaGend Global Medical Services Pte Ltd, Singapore
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan G.K., Japan
Speaker(s)
New Era for Product Information in Digital Health and Pharmacovigilance: FHIR and Electronic Product Information (ePI)
Craig Anderson
Director, Data Standards & Continuous Improvement, Pfizer, Canada
Gravitate – Health ePI on FHIR in EU and beyond
Anne Moen, PhD, MSc, RN
Professor, Faculty of Medicine, Coordinator, Gravitate-Health , University of Oslo, Norway
Current and Future e-labeling in Japan ~Considering Interoperability (HL7 FHIR) from a Health Care Professional Perspective ~
Yoshihiro Aoyagi, MS
Manager, Department of Medical Information, National Cancer Center Hospital East, Japan
Digital health and product information in Japan
Arisa Toyoda
Pharmaceutical Safety Division, Pharmaceutical Safety, Ministry of Health, Labour and Welfare, Japan
Updates for Pharmacovigilance initiatives in China
Yuan Meng
Head of Medical Office R&D, I-Mab Biopharma , China
Have an account?